Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism

Bawei Chenxiang Wan (BCW), a well-known traditional Chinese Tibetan medicine formula, is effective for the treatment of acute and chronic cardiovascular diseases. In the present study, we investigated the effect of BCW in cardiac hypertrophy and underlying mechanisms. The dose of 0.2, 0.4, and 0.8 g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Pharmacol
Hauptverfasser: Zhang, Xiaoying, Zhang, Zhiying, Wang, Pengxiang, Han, Yiwei, Liu, Lijun, Li, Jie, Chen, Yichun, Liu, Duxia, Wang, Jinying, Tian, Xiaoying, Zhao, Qin, Yan, Fengxia
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Pharmacology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8209424/
https://ncbi.nlm.nih.gov/pubmed/34149410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.653901
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge